78 active not recruiting. 78 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 78 | Active not recruiting 78 |
Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults Group A, Group B - Influenza | Phase 4 | Active not recruiting | Ab&B Bio-tech Co., Ltd.JS | 138 | 2026-10-10 | 2026-10-16 |
| Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo blood sample collection - Mpox | Phase 4 | Active not recruiting | Institute of Tropical Medicine, Belgium | 300 | 2026-05-15 | 2026-06-11 |
| Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia Recombinant Herpes Zoster Vaccine (Shingrix) - Cardiovascular Disease, Dementia | Phase 4 | Active not recruiting | Tor Biering-Sørensen | 168460 | 2026-04-28 | 2026-10-14 |
| Thymosin Alpha 1 and IgM Levels in Sepsis Thymalfasin - Sepsis, Septic Shock | Phase 4 | Active not recruiting | Southeast University, China | 36 | 2026-02-20 | 2026-11-06 |
| Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years bivalent HPV vaccine, 9-valent HPV vaccine - HPV Infection | Phase 4 | Active not recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 400 | 2025-12-20 | 2026-06-11 |
| Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses Flu Vaccine, Biological samples - Volunteers, Flu Vaccine | Phase 4 | Active not recruiting | Centre Hospitalier Universitaire de Saint Etienne | 30 | 2025-12-05 | 2025-12-30 |
| REVIVE (Response to the Ebola Virus Vaccine) rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO) - Ebola Virus Disease | Phase 4 | Active not recruiting | Tulane University | 40 | 2025-12-01 | 2026-06-04 |
| A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) mRNA-1273, mRNA-1283, Placebo - SARS-CoV-2 | Phase 4 | Active not recruiting | ModernaTX, Inc. | 30000 | 2025-11-26 | 2026-09-28 |
| Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM WHO-recommended periodic presumptive treatment, Doxycycline post-exposure prophylaxis - Gonorrhea Male, Chlamydia (Male) | Phase 4 | Active not recruiting | University of Washington | 2900 | 2025-10-29 | 2026-11-02 |
| Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart H5N1 vaccine (Arepanrix), Saline (as a placebo) - H5N1 Influenza, H5N1 Virus | Phase 4 | Active not recruiting | Canadian Immunization Research Network | 312 | 2025-10-14 | 2026-01-16 |
| Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine LAIV - Influenza | Phase 4 | Active not recruiting | Jiangsu Province Centers for Disease Control and Prevention | 60 | 2025-10-12 | 2025-11-18 |
| COVID-19 Reactogenicity Nuvaxovid (NVX-CoV2705), mNEXSPIKE mRNA-1283 - COVID-19 | Phase 4 | Active not recruiting | Marcel Curlin | 1000 | 2025-10-01 | 2026-03-04 |
| The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study Live attenuated influenza vaccine, Placebo nasal spray, recombinant hemagglutinin influenza vaccine - Influenza | Phase 4 | Active not recruiting | The University of Hong Kong | 600 | 2025-10-01 | 2026-05-15 |
| Assessing Gingivitis and Plaque From a Marketed Toothpaste Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentifrice, Sodium monofluorophosphate dentifrice - Gingivitis | Phase 4 | Active not recruiting | Procter and Gamble | 120 | 2025-08-30 | 2025-09-23 |
| Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM DoxyODPrEP, DoxyPEP - Sexually Transmitted Diseases, Bacterial, Syphilis | Phase 4 | Active not recruiting | Chinese University of Hong Kong | 300 | 2025-03-29 | 2026-06-05 |
| Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days, Vasoactive drug therapies - Shock, Preterm Birth Complication | Phase 4 | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 76 | 2025-02-01 | 2025-11-25 |
| Clinical Study of Esketamine in Patients With Sepsis Undergoing Invasive Mechanical Ventilation Esketamine, Remifentanil - Sepsis, Mechanical Ventilation | Phase 4 | Active not recruiting | Second Affiliated Hospital of Nanchang University | 80 | 2025-01-01 | 2026-04-29 |
| Vaccination Against Influenza Pre-discharge in Heart Failure Influenza vaccination - Heart Failure | Phase 4 | Active not recruiting | Wroclaw Medical University | 200 | 2024-12-31 | 2025-07-23 |
| OM 85 to Prevent Respiratory Infections in Older At Risk Patients Bacterial Lysate, Placebo - Respiratory Tract Infections (RTI) | Phase 4 | Active not recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 360 | 2024-12-19 | 2025-09-17 |
| Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas Liaoning Chengda Inactivated Japanese Encephalitis Vaccine - Japanese Encephalitis | Phase 4 | Active not recruiting | Liaoning Chengda Biotechnology CO., LTD | 250 | 2024-11-14 | 2024-12-13 |
Showing 20 of 78. Sign in to see all of them.
Influenza, Human (11) · Hepatitis B, Chronic (7) · Papillomavirus Infections (6) · COVID-19 (5) · Sepsis (5) · Surgical Wound Infection (4) · HIV Infections (3) · Latent Tuberculosis (3) · Acquired Immunodeficiency Syndrome (2) · Cardiovascular Diseases (2) · Chlamydia Infections (2) · Diabetes Mellitus (2) · Fibrosis (2) · Gonorrhea (2) · Hepatitis (2)
Virus Diseases (47) · Pathologic Processes (31) · Pathological Conditions, Signs and Symptoms (31) · RNA Virus Infections (28) · Communicable Diseases (23) · Respiratory Tract Diseases (21) · DNA Virus Infections (19) · Disease Attributes (19) · Respiratory Tract Infections (19) · Urogenital Diseases (19) · Bacterial Infections and Mycoses (15) · Blood-Borne Infections (15) · Bacterial Infections (14) · Genital Diseases (14)
Influenza Vaccines (6) · tenofovir alafenamide (5) · Emtricitabine (3) · Isoniazid (3) · Azithromycin (2) · Human Papillomavirus Recombinant Vaccine nonavalent (2) · Injections (2) · Papillomavirus Vaccines (2) · Tenofovir (2) · Therapeutics (2) · human papillomavirus vaccine, L1 type 16, 18 (2) · rifapentine (2) · sofosbuvir-velpatasvir drug combination (2) · 2019-nCoV Vaccine mRNA-1273 (1) · Anti-Bacterial Agents (1)
University of Washington (4) · Duke University (2) · Taichung Veterans General Hospital (2) · The University of Hong Kong (2) · Ab&B Bio-tech Co., Ltd.JS (1) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Asan Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Boston Medical Center (1) · British Columbia Centre for Disease Control (1) · CanSino Biologics Inc. (1) · Canadian Immunization Research Network (1) · Carilion Clinic (1) · Catherine Anne Chappell (1) · Centre Hospitalier Universitaire Saint Pierre (1)
United States (29) · China (11) · Canada (5) · Democratic Republic of the Congo (3) · France (3) · Hong Kong (3) · South Africa (3) · South Korea (3) · Taiwan (3) · Brazil (2) · Kenya (2) · Mexico (2) · Belgium (1) · Botswana (1) · Costa Rica (1)
Abbey B Berenson, MD, PhD (1) · Aimee R Kreimer (1) · Anna Wald, MD (1) · Assoc. Prof. Daniel Paris (1) · Benjamin J Cowling, PhD (1) · Caiyan Zhao, MD (1) · Candace Parker-Autry, MD (1) · Carl G Streed, MD MPH (1) · Carol L Wagner, MD (1) · Catherine Chappell, MD, MSc (1)
PMID 36748942, PMID 41276263, PMID 27230467, PMID 28404091, PMID 28404092, PMID 28427875, PMID 29405329, PMID 29696665, PMID 31199513, PMID 31271737, PMID 31777965, PMID 32078808, PMID 32087795, PMID 32282538, PMID 32304611, PMID 32818460, PMID 33217163, PMID 33404182, PMID 33857679, PMID 34244284, PMID 34857420, PMID 34862278, PMID 36944116, PMID 37382155, PMID 38506889, PMID 39633426, PMID 39697201, PMID 39914435, PMID 40356381, PMID 40390028, PMID 40391688, PMID 40694414, PMID 40973113, PMID 41265006, PMID 41337735, PMID 41494183, PMID 41635193, PMID 41638418, PMID 41679320, PMID 41785036, PMID 41873979, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42688087, PMID 42843284
2025 (2), 1UG1EY028088 (1), 2023 (1), R01AG064800 (1), R01AI179838 (1), U01AI162463 (1), U01AI165452 (1), U54CK000613 (1)